A. Natale et al., SAFETY OF NURSE-ADMINISTERED DEEP SEDATION FOR DEFIBRILLATOR IMPLANTATION IN THE ELECTROPHYSIOLOGY LABORATORY, Journal of cardiovascular electrophysiology, 7(4), 1996, pp. 301-306
Implantation of implantable cardioverter defibrillators (ICDs) in the
electrophysiology (EP) laboratory has been shown to be safe. However,
general endotracheal anesthesia and/or administration of sedatives is
mostly performed by anesthesiologists. In 53 patients undergoing ICD i
mplantation in the EP laboratory, we prospectively assessed whether de
ep sedation without endotracheal intubation can be administered by nur
sing personnel under medical supervision, The mean patient age was 67
+/- 7 years, and the mean ejection fraction was 32 +/- 8%. All ICDs we
re placed in the abdomen requiring lead tunneling, Patients were monit
ored with pulse oximetry and noninvasive blood pressure recordings. Th
e level of consciousness and vital signs were evaluated at 5-minute in
tervals, Deep sedation was induced with phenergan and midazolam and ma
intained with either meperidine or fentanyl. The mean doses given were
as follows: phenergan 0.33 +/- 0.15 mg/kg, midazolam 0.05 +/- 0.03 mg
/kg, meperidine 0.46 +/- 0.10 mg/kg per hour, and fentanyl 1.94 +/- 0.
71 mu g/kg per hour. None of the patients required intubation during o
r after the procedure, No death occurred and no patient had any recoll
ection of the procedure. In three patients, O-2 desaturation was easil
y managed by transient reversion of the effects of meperidine or fenta
nyl with naloxone, No patient experienced prolonged hospitalization af
ter the implant (mean 2.4 +/- 0.5 days). In conclusion: (1) adequate s
edation for ICD implantation and testing can be administered safely by
nursing staff in the EP lab; (2) optimum sedation protocols should in
clude drugs easy to reverse in case of excessive respiratory depressio
n; and (3) this may represent a more cost-effective approach to ICD im
plantation.